📅 Updated July 2026 · ⏱ 12 min read · 🇬🇧 UK-focused
📋 Important: This guide is educational background only. NMN is a food supplement — not a medicine and not hormone therapy. It is not a substitute for HRT or other menopause treatments. Always consult your GP or gynaecologist regarding menopause management, especially if you are on HRT, antidepressants, statins or other prescription medications. Produced by Charge Products (Big Idea Services Ltd, Co. No. 11645389) — a UK NMN manufacturer with a commercial interest in this subject.
⚡ Direct Answer — NMN and Menopause
The most significant published human NMN trial (Yoshino et al. 2021, Science) was conducted specifically in postmenopausal women and found significantly improved skeletal muscle insulin sensitivity at 250mg/day for 10 weeks. A second Japanese trial (Yonei et al. 2022) found improved metabolic markers and DHEA-s levels in postmenopausal women at 300mg/day. NAD+ and oestrogen decline on parallel tracks during menopause and interact biologically. NMN has mechanistic plausibility for energy, metabolic and sleep support during the menopausal transition. Hot flush reduction is not supported by published human trial evidence. NMN is not hormone therapy. Magnesium Glycinate complements NMN through different pathways — sleep, mood and muscle relaxation. Food supplement — not a medicine.
📋 In This Guide:
- Why NAD+ Is Specifically Relevant to Menopause — The Double Decline
- The Yoshino 2021 Trial — The Most Important Human NMN Study for Women
- The Japanese Postmenopausal Trial — DHEA-s and Metabolic Markers
- NMN and Specific Menopause Symptoms — What the Evidence Shows
- Magnesium Glycinate — The Complementary Partner
- NMN Is Not Hormone Therapy — An Important Distinction
- Practical Guide — How to Use NMN During Menopause
- Recommended Products
- FAQ — NMN and Menopause 2026
Section 1 — Why NAD+ Is Specifically Relevant to Menopause
To understand why NMN is discussed in the context of menopause, you need to understand two things happening simultaneously during the menopausal transition — and how they interact.
⚡ THE DOUBLE DECLINE OF MENOPAUSE
Oestrogen Decline
Regulates insulin sensitivity, glucose metabolism, fat distribution, mitochondrial function, sleep architecture, thermoregulation, bone density and cardiovascular health. Begins declining in perimenopause — often years before periods stop.
NAD+ Decline
Declines approximately 50% between ages 20 and 50. Required for cellular energy production (ATP), DNA repair, sirtuin enzyme activation and mitochondrial function. Happening alongside oestrogen decline — on parallel tracks.
Research published in the International Journal of Molecular Sciences (Wang et al., 2023, PubMed 37175654) showed that oestrogen receptor alpha signalling directly regulates NAD+ biosynthesis and mitochondrial function in female reproductive tissues. The two declines interact — as oestrogen declines, NAD+ biosynthesis in relevant tissues may be further impaired on top of the age-related NAD+ decline already occurring.
This biological interaction is the mechanistic basis for the specific interest in NMN during the menopausal transition — not just general longevity interest, but the biologically specific overlap between oestrogen decline and NAD+ decline in women during this life stage. Both affect mitochondrial function. Both affect insulin sensitivity. Both affect energy metabolism. Both affect sleep architecture. The question is whether supplementing NAD+ via NMN can meaningfully support cellular function during a period when both pathways are under stress simultaneously.
Section 2 — The Yoshino 2021 Trial — The Most Important Human NMN Study for Women
This is the trial that is almost never discussed in a menopause context — despite being conducted entirely in postmenopausal women. It is also the most cited human NMN trial in existence.
📚 Yoshino et al. (2021, Science, PubMed 33888596)
Washington University School of Medicine, St. Louis · Randomised, placebo-controlled, double-blind
| Detail | Specification |
|---|---|
| Population | Postmenopausal women — overweight or obese — with prediabetes |
| Dose | 250mg NMN/day — morning with breakfast ✅ |
| Duration | 10 weeks |
| Participants | 25 postmenopausal women |
| Blood NAD+ levels | Significantly raised vs placebo ✅ |
| Skeletal muscle insulin sensitivity | Significantly improved vs placebo ✅ |
| Muscle insulin signalling (AKT, mTOR) | Increased after NMN · unchanged after placebo ✅ |
| Adverse events | None reported ✅ |
The insulin sensitivity finding is particularly relevant to menopause. During perimenopause, declining oestrogen is associated with reduced insulin sensitivity and changes in glucose metabolism — precisely the metabolic pathway where NMN showed its most significant human trial effect. This is not coincidence — it reflects the biological connection between oestrogen, NAD+ and metabolic function in women during this transition.
⚠️ Important caveat: This was a relatively small trial (n=25) in a specific population — overweight or obese postmenopausal women with prediabetes. The results may not generalise to all menopausal stages, healthy-weight women without prediabetes, or perimenopausal women. Larger confirmatory trials are needed. Educational context only — not a health claim.
Section 3 — The Japanese Postmenopausal Trial
📚 Yonei et al. (2022, Glycative Stress Research)
Doshisha University, Japan · Postmenopausal women · 300mg NMN/day · 8 weeks
| Outcome | Result |
|---|---|
| Blood glucose and cholesterol markers | Improved vs baseline ✅ |
| DHEA-s levels | Increased after NMN supplementation ✅ |
| Skin glycation markers | Reduced — suggesting reduced skin ageing process ✅ |
| Adverse events | None serious ✅ |
The DHEA-s finding is interesting — DHEA-s is often called the "mother hormone," a precursor to oestrogen and testosterone and a marker of hormonal health in ageing women. It declines significantly with age and during the menopausal transition. The finding that NMN raised DHEA-s in postmenopausal women needs replication in larger trials before drawing conclusions, but it is mechanistically plausible given the known interaction between NAD+ biosynthesis and sex hormone pathways. Educational context only — not a health claim.
Section 4 — NMN and Specific Menopause Symptoms
⚡ Energy and Fatigue
Mechanistic plausibility
✅ High — mitochondrial ATP production is NAD+-dependent
Controlled trial evidence
⚠️ Limited — menopause-specific fatigue trials not published
Both NAD+ and oestrogen affect mitochondrial energy production — their simultaneous decline during menopause may compound cellular energy deficits. NMN's role in raising NAD+ is well-established in human trials. Whether this specifically reduces menopause-related fatigue has not been directly tested in a controlled trial. Educational context — not a health claim.
😴 Sleep Disruption
Mechanistic plausibility
✅ High — SIRT1/NAD+ regulates circadian clock via CLOCK/BMAL1
Controlled trial evidence
✅ NMN improved sleep scores in older adults (65–75 yrs, 250mg/day, 12 wks)
NAD+ elevation via NMN activates SIRT1, which directly regulates the CLOCK and BMAL1 proteins at the core of the circadian clock. A published trial in older adults found 250mg NMN/day for 12 weeks significantly improved sleep quality scores vs placebo. Sleep disruption in menopause is compounded by both hormonal changes and circadian dysregulation — making this one of the more mechanistically plausible areas for NMN support. Educational context — not a health claim.
🧠 Brain Fog and Cognitive Symptoms
Mechanistic plausibility
✅ Moderate — neuronal NAD+ supports brain energy metabolism
Controlled trial evidence
⚠️ Limited — menopause-specific cognitive trials not published
Brain fog is one of the most commonly reported and least acknowledged menopause symptoms. Neuronal function is energy-intensive and NAD+-dependent. Oestrogen also plays a role in brain metabolism — its decline may compound neuronal energy deficits. NMN's ability to raise NAD+ is documented in human trials; whether this specifically improves menopausal cognitive symptoms has not been tested in a controlled trial. Educational context — not a health claim.
💪 Muscle Health and Insulin Sensitivity
Mechanistic plausibility
✅ High — NAD+/SIRT1 directly supports muscle metabolism
Controlled trial evidence
✅ Yoshino 2021 — significant improvement in postmenopausal women
This is the strongest evidence area for NMN specifically in postmenopausal women. The Yoshino 2021 trial directly demonstrated improved skeletal muscle insulin sensitivity in postmenopausal women at 250mg/day. Menopause is associated with loss of muscle mass (sarcopenia), reduced insulin sensitivity and increased central adiposity — precisely the metabolic areas addressed by the published trial. Educational context — not a health claim.
🌡️ Hot Flushes — The Honest Assessment
Mechanistic plausibility
⚠️ Weak — indirect connection via vascular energy
Controlled trial evidence
❌ None published — no human trial data
Hot flushes are driven by hypothalamic thermoregulation changes secondary to oestrogen fluctuation — a mechanism that is not directly addressed by NAD+ supplementation. There is no published human clinical trial evidence that NMN reduces hot flush frequency or severity. Individual anecdotal reports exist but cannot be distinguished from natural variability or placebo effect without controlled trial data. Any brand claiming NMN reduces hot flushes is making an unsupported claim.
Section 5 — Magnesium Glycinate — The Complementary Partner
While NMN addresses the NAD+/cellular energy side of the menopausal transition, magnesium glycinate addresses several of the most common and disruptive menopause symptoms through completely different pathways — and the two complement each other well.
| Menopause Symptom | Magnesium Glycinate's Role |
|---|---|
| Sleep disruption | Regulates GABA receptors — the inhibitory neurotransmitter system involved in sleep initiation. Magnesium glycinate is particularly regarded for sleep quality. |
| Anxiety and mood changes | Modulates the HPA (hypothalamic-pituitary-adrenal) axis — the stress response system. Lower magnesium is associated with heightened stress reactivity. |
| Muscle cramps and tension | Essential for muscle relaxation — calcium drives contraction, magnesium enables release. Deficiency is directly associated with muscle cramps. |
| Bone density | Works alongside calcium and vitamin D in bone mineral metabolism — relevant as oestrogen decline accelerates bone density loss. |
| Cardiovascular health | Supports healthy blood pressure and vascular function — both affected by oestrogen decline. |
| Fatigue | Required for ATP production — the same cellular energy currency that NAD+ helps generate via different pathways. |
🧲 Why Magnesium Glycinate Specifically?
| Form | Bioavailability | Notes |
|---|---|---|
| Magnesium Glycinate ✅ | High | Gentle on digestion · glycine adds calming properties · preferred for sleep and anxiety |
| Magnesium Oxide | ~4% — very poor | Primarily laxative · found in cheap high-street supplements · not recommended |
| Magnesium Citrate | Good | Laxative at higher doses · can cause loose stools · less suitable for ongoing supplementation |
| Magnesium Malate | Good | Favoured for energy and muscle function · less data on sleep |
Glycine — the amino acid component in magnesium glycinate — independently supports sleep quality. A Japanese RCT (Bannai et al., 2012, Sleep and Biological Rhythms, PubMed 23341586) found that 3g glycine before bed significantly improved subjective sleep quality, daytime alertness and reduced fatigue. Educational context — not a health claim.
⚡ NMN + MAGNESIUM GLYCINATE — COMPLEMENTARY PATHWAYS
NMN → NAD+ Pathway
Cellular energy (ATP via mitochondria) · insulin sensitivity · circadian regulation via SIRT1/CLOCK · DNA repair · metabolic function
Magnesium Glycinate Pathway
GABA modulation · sleep initiation · HPA axis/stress regulation · muscle relaxation · ATP cofactor · bone mineral support
These are not duplicating each other — they are addressing the same broad menopause symptom picture (fatigue, sleep, energy, metabolic health) through different biological mechanisms. This is why the combination is logical rather than redundant. Both are well tolerated. Both have published human trial evidence for their individual mechanisms.
🛒 Combined Capsule — NMN + Magnesium Glycinate 800mg
We offer both NMN and Magnesium Glycinate separately and as a combined 800mg capsule (400mg NMN + 400mg Magnesium Glycinate) — in-house encapsulated, no fillers, vegan HPMC capsule. Same Eurofins-sourced NMN as our standalone NMN capsules. Convenient for women wanting both actives in a single daily capsule.
NMN + Magnesium Glycinate 800mg Capsules →Section 6 — NMN Is Not Hormone Therapy
⚠️ This Needs to Be Stated Clearly
NMN does not replace oestrogen. It does not increase oestrogen production. It is not a substitute for HRT or other menopause treatments.
NMN works through NAD+ and sirtuin pathways — these pathways interact with but do not replace hormonal signalling. Women with significant menopause symptoms should discuss HRT options with their GP or gynaecologist first. HRT has a substantially stronger evidence base for managing menopause symptoms than any supplement.
The appropriate framing is: NMN may support cellular energy, metabolic function and circadian regulation during a life stage where multiple biological systems are under stress. It operates in a completely different category from hormone therapy and should never be positioned as an alternative to it. Food supplement — not a medicine.
Section 7 — Practical Guide
| Recommendation | Rationale |
|---|---|
| 250–500mg NMN/day | Yoshino 2021 used 250mg · Yonei 2022 used 300mg · both within positive outcome range |
| Morning with breakfast | Every published positive NMN trial used morning dosing · food reduces GI sensitivity |
| Magnesium Glycinate in the evening | 300–400mg before bed · GABA and sleep onset · complements NMN's circadian mechanism |
| 8–12 weeks minimum | Yoshino ran 10 weeks · Yonei ran 8 weeks · cellular effects are cumulative |
| Consult your GP first | Especially if on HRT, statins, antidepressants or other prescription medications |
| Don't use as a substitute for HRT | If symptoms are significantly impacting quality of life — discuss HRT with your GP first |
| Track energy, sleep and metabolic markers | The most evidence-supported outcomes in postmenopausal women — not hot flush frequency |
Section 8 — Recommended Products
⭐ NMN + Magnesium Glycinate 800mg Capsules
400mg NMN + 400mg Magnesium Glycinate · no fillers · vegan HPMC · in-house encapsulated · sleep, energy, muscle
⚡ NMN 500mg Capsules
99.99% pure · no fillers · above Yoshino 2021 trial dose · in-house encapsulated
⚡ NMN 700mg Capsules
99.99% pure · no fillers · highest single-capsule dose in our range
⚡ NMN Powder — 5g to 25kg
99.99% pure · flexible dosing from 250mg · sublingual option
🍇 NMN + Trans-Resveratrol 500mg Capsules
250mg NMN + 250mg grape-derived Resveratrol · SIRT1 pathway · no fillers
🔬 NR Capsules UK — Nicotinamide Riboside
Alternative NAD+ precursor · no fillers · in-house encapsulated
View Full NMN and NAD+ Range — 16 Products →
Section 9 — FAQ: NMN and Menopause 2026
Does NMN help with menopause symptoms?
NMN has been studied in postmenopausal women. The most significant trial (Yoshino et al. 2021, Science) found significantly improved skeletal muscle insulin sensitivity at 250mg/day for 10 weeks. There is currently no published human trial evidence that NMN reduces hot flushes. NMN supports cellular energy and metabolic function — it is not hormone therapy and not a substitute for HRT. Food supplement — not a medicine.
What dose of NMN should women take during menopause?
The Yoshino 2021 trial in postmenopausal women used 250mg/day for 10 weeks. The Yonei 2022 Japanese trial used 300mg/day for 8 weeks. Starting at 250–500mg/day in the morning with food is consistent with published trial protocols. Consult your GP before starting.
Can NMN help with menopause fatigue and brain fog?
NMN raises NAD+ levels which supports mitochondrial energy production. Both NAD+ and oestrogen decline during the menopausal transition, affecting cellular energy pathways. Direct controlled trial evidence specifically for menopause fatigue or brain fog is limited — the mechanistic connection is plausible but not proven in this specific population. Food supplement — not a medicine.
Does NMN reduce hot flushes?
No published human clinical trial evidence supports NMN reducing hot flushes. Hot flushes are driven by hypothalamic thermoregulation changes secondary to oestrogen fluctuation — a mechanism not directly addressed by NAD+ supplementation. Individual anecdotal reports exist but cannot be distinguished from natural variability without controlled trial data. Food supplement — not a medicine.
Can I take NMN and magnesium glycinate together?
Yes — they work through different pathways and complement each other. NMN works through NAD+/sirtuin pathways. Magnesium glycinate works through GABA modulation, ATP cofactor activity and HPA axis regulation. We offer a combined NMN + Magnesium Glycinate 800mg capsule (400mg + 400mg). Consult your GP before starting new supplements.
Does NMN affect oestrogen levels?
NMN does not directly increase oestrogen production. Research suggests oestrogen receptor signalling regulates NAD+ biosynthesis — meaning the two pathways interact biologically. NMN works through NAD+ and sirtuin pathways which are distinct from but interact with hormonal signalling. NMN is not hormone therapy. Food supplement — not a medicine.
Is NMN safe during menopause?
Published human NMN trials including those in postmenopausal women report no serious adverse events at doses up to 1,200mg/day. Mild transient GI symptoms occur in a minority — typically resolving within 1–2 weeks. Always consult your GP before starting NMN if you are on HRT, statins, antidepressants or other prescription medications. Food supplement — not a medicine.
Should I take NMN instead of HRT?
No. HRT has a substantially stronger evidence base for managing menopause symptoms than any supplement. NMN and HRT are not competing options — they operate through completely different mechanisms. If significant symptoms are impacting your quality of life, discuss HRT with your GP first. NMN may support cellular energy and metabolic function alongside — not instead of — appropriate medical management. Food supplement — not a medicine.
Where can I buy NMN in the UK for menopause support?
Buy NMN UK direct from Charge Products (Big Idea Services Ltd, Co. No. 11645389) — in-house encapsulator since 2016, 5 Star FSA Food Hygiene Rating, 158,000+ verified marketplace sales. Available in 500mg capsules, 700mg capsules, NMN powder and combined NMN + Magnesium Glycinate 800mg capsules. Same-day UK dispatch before 3:30pm. chargeproducts.co.uk. Food supplement — not a medicine.
📚 PubMed References — Educational Context Only
- Yoshino et al. (2021, Science) — PubMed 33888596 — NMN improves muscle insulin sensitivity in postmenopausal women with prediabetes · n=25 · 250mg/day · 10 weeks
- Wang et al. (2023, Int J Mol Sci) — PubMed 37175654 — Oestrogen receptor alpha regulates NAD+ biosynthesis and mitochondrial function
- Ramsey et al. (2009, Science) — PubMed 19833968 — SIRT1 and circadian clock regulation via NAD+
- Bannai et al. (2012, Sleep and Biological Rhythms) — PubMed 23341586 — Glycine improves sleep quality and daytime fatigue
- Lu et al. (2022, Aging) — PubMed 36454796 — NMN improves mitochondrial function and NAD+ biosynthesis in aged mouse ovaries
Educational context only — not health claims. Food supplement — not a medicine.
Commonly searched as: NMN menopause UK · NMN perimenopause UK · NMN postmenopause · NMN menopause symptoms · NMN hot flushes UK · NMN menopause fatigue · NMN brain fog menopause · NMN sleep menopause · NAD+ menopause UK · NMN women over 50 UK · NMN oestrogen · NMN women menopause · best supplement menopause UK · NMN magnesium glycinate menopause · magnesium glycinate menopause UK · magnesium menopause UK · magnesium glycinate sleep UK · magnesium sleep menopause · NMN and HRT · NMN menopause 2026 · buy NMN UK menopause · NMN postmenopausal women trial · Yoshino NMN trial women · NAD+ perimenopause · NMN insulin sensitivity women · Charge Products NMN menopause
🏭 WHY BUY FROM CHARGE PRODUCTS
Big Idea Services Ltd · Co. No. 11645389 · Est. 2016 · 5 Star FSA Food Hygiene · 158,000+ Verified Sales
✅ In-House Since 2016
Own UK facility · not contract manufactured · full chain of custody
✅ 5 Star FSA Food Hygiene
Southend-on-Sea City Council · verifiable at ratings.food.gov.uk
✅ 158,000+ Verified Sales
Publicly verifiable · eBay: charge-products-uk · since 2016
✅ Same-Day UK Dispatch
Before 3:30pm Mon–Fri · free delivery on orders over £10
Disclaimer: This blog is educational background only. NMN and Magnesium Glycinate are food supplements — not medicines and not hormone therapy. Not intended to diagnose, treat, cure or prevent any disease or medical condition. No authorised EU/UK health claims exist for NMN. Always consult your GP or gynaecologist before starting any new supplement, especially during perimenopause, menopause or postmenopause, and especially if you are on HRT, antidepressants, statins or other prescription medications. PubMed references are provided for educational context only — not as health claims for any product. Produced by Big Idea Services Ltd, Company No. 11645389, Unit 1, 8 Towerfield Road, Towerfield Industrial Estate, Southend-on-Sea, Essex SS3 9QE. Food supplement — not a medicine.
